162 related articles for article (PubMed ID: 856605)
1. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
Pérez-Mateo M; Erill S
Eur J Clin Pharmacol; 1977 Mar; 11(3):225-31. PubMed ID: 856605
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
Perez-Mateo M; Erill S
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
[TBL] [Abstract][Full Text] [Related]
3. Blood binding of selezen (imidazole salicylate) in man.
Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
[TBL] [Abstract][Full Text] [Related]
4. Protein binding of salicylate in cutaneous hepatic porphyria.
Steele WH; Boobis SW; Moore MR; Goldberg A; Brodie MJ; Summer DJ
Eur J Clin Pharmacol; 1978 Jun; 13(4):309-13. PubMed ID: 668790
[TBL] [Abstract][Full Text] [Related]
5. Decreased drug binding in serum from patients with chronic hepatic disease.
Wallace S; Brodie MJ
Eur J Clin Pharmacol; 1976 Mar; 09(5-6):429-32. PubMed ID: 971706
[TBL] [Abstract][Full Text] [Related]
6. The protein binding of some drugs in plasma from patients with alcoholic liver disease.
Affrime M; Reidenberg MM
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):267-9. PubMed ID: 1233223
[TBL] [Abstract][Full Text] [Related]
7. Decreased quinidine plasma protein binding during hemodialysis.
Kessler KM; Perez GO
Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
Erill S; Calvo R; Carlos R
Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
[TBL] [Abstract][Full Text] [Related]
9. Plasma protein binding of azapropazone in patients with kidney and liver disease.
Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of etomidate in different age groups and in patients with chronic respiratory insufficiency.
Carlos R; Calvo R; Erill S
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):171-4. PubMed ID: 7263105
[TBL] [Abstract][Full Text] [Related]
11. Protein binding of salicylate in uremic and normal plasma.
Borgå O; Cederlöf IO; Ringberger VA; Norlin A
Clin Pharmacol Ther; 1976 Oct; 20(4):464-75. PubMed ID: 975718
[TBL] [Abstract][Full Text] [Related]
12. Contributions of hippurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humans.
Gulyassy PF; Jarrard E; Stanfel LA
Biochem Pharmacol; 1987 Dec; 36(24):4215-20. PubMed ID: 3120733
[TBL] [Abstract][Full Text] [Related]
13. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
Verbeeck RK; De Schepper PJ
Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
[TBL] [Abstract][Full Text] [Related]
14. Blood collection techniques, heparin and quinidine protein binding.
Kessler KM; Leech RC; Spann JF
Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
[TBL] [Abstract][Full Text] [Related]
15. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.
Kates RE; Sokoloski TD; Comstock TJ
Clin Pharmacol Ther; 1978 Jan; 23(1):30-5. PubMed ID: 618708
[TBL] [Abstract][Full Text] [Related]
16. The effect of renal transplantation on plasma protein binding.
Affrime MB; Blecker DL; Lyons PJ; Pitone JM; Swartz CD; Lowenthal DT
J Dial; 1979; 3(2-3):207-18. PubMed ID: 389974
[TBL] [Abstract][Full Text] [Related]
17. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
Olsen GD; Bennett WM; Porter GA
Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma binding of quinidine after surgery: a preliminary report.
Fremstad D; Bergerud K; Haffner JF; Lunde PK
Eur J Clin Pharmacol; 1976; 10(6):441-4. PubMed ID: 63371
[TBL] [Abstract][Full Text] [Related]
19. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
[TBL] [Abstract][Full Text] [Related]
20. Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency.
Pacifici GM; Bianchetti G; Viani A; Rizzo G; Carrai M; Allen J; Morselli PL
Eur J Clin Pharmacol; 1989; 37(1):29-32. PubMed ID: 2574111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
